http://www.emedicine.com/emerg/topic574.htm

 

eMedicine World Medical Library

Sponsor:eresidency.com

 

Sponsors do not influence content.

 

Use the our online Merriam-Webster medical dictionary.

 

eMedicine Journal > Emergency Medicine > Infectious Diseases
Tetanus

Author Information | Introduction | Clinical | Differentials | Workup | Treatment | Medication | Follow-up | Miscellaneous | Pictures | Bibliography

 

AUTHOR INFORMATION

Section 1 of 11    Click here to go to the top of this pageClick here to go to the next section in this topic

Authored by Daniel J Dire, MD, FACEP, COL, MC, USAR, USAWC Senior Service Fellow, Center for Strategic Analysis, University of Texas at Austin

Daniel J Dire, MD, FACEP, COL, MC, USAR, is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Association of Military Surgeons of the US, and Society for Academic Emergency Medicine

Edited by Theodore Gaeta, Residency Director, Clinical Associate Professor of Emergency Medicine in Medicine, Department of Emergency Medicine, New York Methodist Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Charles V Pollack, Jr, MD, MA, University of Pennsylvania College of Medicine, Associate Professor of Emergency Medicine, Chairman, Department of Emergency Medicine, Pennsylvania Hospital

Author's Email:

Daniel J Dire, MD, FACEP, COL, MC, USAR

 

Click here to view conflict-of-interest information on the author of this topic

Editor's Email:

Theodore Gaeta

 

 

eMedicine Journal, May 18 2001, Volume 2, Number 5

INTRODUCTION

Section 2 of 11   Click here to go to the next section in this topic Click here to go to the top of this pageClick here to go to the next section in this topic

Background: Tetanus is an illness characterized by an acute onset of hypertonia, painful muscular contractions (usually of the muscles of the jaw and neck), and generalized muscle spasms without other apparent medical causes.

Despite widespread immunization of infants and children in the US since the 1940s, tetanus still occurs in the US. In the 1990s, tetanus is a severe disease primarily of older adults who are unvaccinated or inadequately vaccinated.

Pathophysiology: Clostridium tetani, an obligate anaerobic, gram-positive bacillus, causes tetanus. This bacterium is nonencapsulated and forms spores, which are resistant to heat, desiccation, and disinfectants. The spores are ubiquitous and are found in soil, house dust, animal intestines, and human feces.

Spores that gain entry can persist in normal tissue for months to years. Under anaerobic conditions, these spores geminate and elaborate tetanospasmin and tetanolysin. Tetanolysin is not felt to be of any significance in the clinical course of tetanus. Tetanospasmin that is released by the maturing bacilli is distributed via the lymphatic and vascular circulations to the end plates of all nerves. Tetanospasmin then enters the nervous system peripherally at the myoneural junction and is transported centripetally into neurons of the central nervous system (CNS).

These neurons become incapable of neurotransmitter release. The neurons, which release gamma-aminobutyric acid (GABA) and glycine, the major inhibitory neurotransmitters, are particularly sensitive to tetanospasmin leading to failure of inhibition of motor reflex responses to sensory stimulation resulting in generalized contractions of the agonist and antagonist musculature characteristic of a tetanic spasm. The shortest peripheral nerves are the first to deliver the toxin to the CNS, which leads to the early symptoms of facial distortion and back and neck stiffness.

Once the toxin becomes fixed to neurons, it cannot be neutralized with antitoxin. Recovery of nerve function from tetanus toxins requires sprouting of new nerve terminals and formation of new synapses.

Frequency:

Developed nations have incidences of tetanus similar to that observed in the US. For instance, only 126 cases were reported in England and Wales between 1984 and 1992.

Mortality/Morbidity: Overall, mortality is approximately 45%. The mortality rate in the US is 6% for those who had previous received 1-2 doses of tetanus toxoid to 15% for those unvaccinated.

Race: In the US, African Americans from the rural south have a greater risk of tetanus.

Sex: A difference in the levels of tetanus immunity exists between genders.

Age: Incidence of tetanus increases with advancing age. Of the patients with tetanus in the US, 54% are older than 59 years and only 5% are younger than 20 years.

CLINICAL

Section 3 of 11   Click here to go to the next section in this topic Click here to go to the top of this pageClick here to go to the next section in this topic

History:

Physical:

Causes:

DIFFERENTIALS

Section 4 of 11   Click here to go to the next section in this topic Click here to go to the top of this pageClick here to go to the next section in this topic

Conversion Disorder
Dislocations, Mandible
Encephalitis
Hypocalcemia
Meningitis
Peritonsillar Abscess
Rabies
Spider Envenomations, Widow
Stroke, Hemorrhagic
Subarachnoid Hemorrhage
Toxicity, Medication-Induced Dystonic Reactions


Other Problems to be Considered:

Intraoral disease
Odontogenic infections
Globus hystericus
Hepatic encephalopathy
Hysteria
Strychnine poisoning
Acute abdomen
Intracranial hemorrhage

WORKUP

Section 5 of 11